Biochemical and imaging markers in patients with thalassaemia.

Biochemical and imaging markers in patients with thalassaemia. Hellenic J Cardiol. 2020 May 06;: Authors: Vlachou M, Kamperidis V, Giannakoulas G, Karamitsos T, Vlachaki E, Karvounis H Abstract Beta-thalassaemia is a genetic disease with different clinical aspects, which can lead to heart failure with a multifactorial mechanism. Over the last years, growing interest has been reported for biomarkers which may help in the diagnosis, staging and prognosis of heart disease at an early stage, in patients with beta-thalassaemia. This review will highlight the current clinical value of cardiac biomarkers in beta-thalassaemia patients and the ongoing research for a possible expanded future use. PMID: 32387594 [PubMed - as supplied by publisher]
Source: Hellenic Journal of Cardiology - Category: Cardiology Tags: Hellenic J Cardiol Source Type: research